Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

npj Precision Oncology
  • View all journals
  • Search
  • My Account Login
  • Content Explore content
  • About the journal
  • Publish with us
  • Sign up for alerts
  • RSS feed
  1. nature
  2. npj precision oncology
  3. articles
  4. article
AI-enabled single-cell dissection of the palmitoylation landscape identifies a multicellular prognostic program in gastric cancer
Download PDF
Download PDF
  • Article
  • Open access
  • Published: 07 March 2026

AI-enabled single-cell dissection of the palmitoylation landscape identifies a multicellular prognostic program in gastric cancer

  • Jun Xu1 na1,
  • You Hu2 na1,
  • Qiao Qiao3 na1,
  • Yongda Lu1,
  • Fan Cen4,
  • Shuoshuo Hou5,
  • Hongbao Yang6,
  • Jian Lv7,
  • Yan Qin8 &
  • …
  • Suhua Xia4 

npj Precision Oncology , Article number:  (2026) Cite this article

  • 2140 Accesses

  • 8 Altmetric

  • Metrics details

We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors present which affect the content, and all legal disclaimers apply.

Subjects

  • Biomarkers
  • Cancer
  • Computational biology and bioinformatics
  • Oncology

Abstract

Gastric cancer remains highly lethal, yet how protein S-palmitoylation shapes tumour ecosystems and clinical outcome is unclear. We integrated single-cell RNA sequencing (119,931 cells from 25 gastric tumours) with spatial transcriptomics and bulk cohorts to delineate palmitoylation-linked states across malignant, immune, and stromal compartments. A palmitoylation-high malignant programme partitioned into three metastasis-enriched subclusters with increased fatty-acid metabolism and Ras–MAPK signalling and predicted worse survival. Spatial mapping and ligand–receptor inference revealed co-localised niches where palmitoylation-high tumour cells interacted with immunosuppressive myeloid cells and distinct CAF subsets, with strengthened pro-angiogenic and pro-fibrotic cues. We derived and validated an 87-gene multicellular palmitoylation signature for risk stratification, and higher scores were consistently associated with adverse outcomes in external cohorts. Drug-response modelling highlighted vulnerabilities involving the HSP90–PI3K/MAPK axis. Functional assays and xenografts confirmed SH3BGRL as a key driver within this poor-prognosis programme.

Similar content being viewed by others

Palmitic acid activates c-Myc via dual palmitoylation-dependent pathways to promote colon cancer

Article Open access 17 February 2026

Identification of specific role of SNX family in gastric cancer prognosis evaluation

Article Open access 17 June 2022

Multi-dimensional omics integrated machine learning framework identifies macrophage-fibroblast-tumor co-infiltration patterns to predict prognosis in gastric cancer

Article Open access 09 December 2025

Data Availability

The datasets generated and/or analysed during the current study are available in the corresponding repositories. RNA sequencing data and associated clinical data for GC samples were retrieved from The Cancer Genome Atlas (TCGA) and can be accessed through the TCGA portal. Single-cell RNA-seq and spatial transcriptomics data are available from the GEO database (accession numbers: GSE167297, GSE184198, OMIX001073). Further inquiries regarding the datasets should be directed to the corresponding authors.

References

  1. Sundar, R. et al. Gastric cancer. Lancet 405, 2087–2102 (2025).

    Google Scholar 

  2. Duan, Y. et al. Helicobacter pylori and gastric cancer: mechanisms and new perspectives. J. Hematol. Oncol. 18, 10 (2025).

    Google Scholar 

  3. Chen, Y. et al. Identification of core immune-related genes CTSK, C3, and IFITM1 for diagnosing Helicobacter pylori infection-associated gastric cancer through transcriptomic analysis. Int J. Biol. Macromol. 287, 138645 (2025).

    Google Scholar 

  4. Wu, L. W. et al. Diffuse gastric cancer: a comprehensive review of molecular features and emerging therapeutics. Target Oncol. 19, 845–865 (2024).

    Google Scholar 

  5. Chen, Y. et al. The current landscape of gastric cancer and gastroesophageal junction cancer diagnosis and treatment in China: a comprehensive nationwide cohort analysis. J. Hematol. Oncol. 18, 42 (2025).

    Google Scholar 

  6. Ford, A. C. et al. Eradication therapy to prevent gastric cancer in helicobacterpylori-positive individuals: systematic review and meta-analysis of randomized controlled trials and observational studies. Gastroenterology 169, 261–276 (2025).

    Google Scholar 

  7. Liu, Y. et al. Traditional Chinese medicine in the treatment of chronic atrophic gastritis, precancerous lesions and gastric cancer. J. Ethnopharmacol. 337, 118812 (2025).

    Google Scholar 

  8. Pei, L. et al. Electroacupuncture reduces duration of postoperative ileus after laparoscopic gastrectomy for gastric cancer: a multicenter randomized trial. Gastroenterology 169, 73–84 (2025).

    Google Scholar 

  9. Shah, S. C. et al. AGA clinical practice update on screening and surveillance in individuals at increased risk for gastric cancer in the united states: expert review. Gastroenterology 168, 405–416.e1 (2025).

    Google Scholar 

  10. Ren, L. et al. Effectiveness of the CANCER-AIMS intervention on nutritional status and symptom management in patients with gastric cancer following gastrectomy: a randomized controlled trial. Int J. Nurs. Stud. 159, 104873 (2024).

    Google Scholar 

  11. Yu, H. et al. Alkannin triggered apoptosis and ferroptosis in gastric cancer by suppressing lipid metabolism mediated by the c-Fos/SREBF1 axis. Phytomedicine 140, 156604 (2025).

    Google Scholar 

  12. Shoji, H. et al. Phosphoproteomic subtyping of gastric cancer reveals dynamic transformation with chemotherapy and guides targeted cancer treatment. Cell Rep. 43, 114774 (2024).

    Google Scholar 

  13. Hwang, K. et al. Targeted degradation of METTL3 against acute myeloid leukemia and gastric cancer. Eur. J. Med Chem. 279, 116843 (2024).

    Google Scholar 

  14. Jiang, X. et al. Eleutheroside A inhibits PI3K/AKT1/mTOR-mediated glycolysis in MDSCs to alleviate their immunosuppressive function in gastric cancer. Int Immunopharmacol. 159, 114907 (2025).

    Google Scholar 

  15. Zhao, Z. et al. Helicobacter pylori activates SLFN4(+)MDSCs to accelerate gastric intestinal metaplasia. iScience 27, 111255 (2024).

    Google Scholar 

  16. Shen, Y., et al. Rg3-lipo biomimetic delivery of paclitaxel enhances targeting of tumors and myeloid-derived suppressor cells. J. Clin. Invest. 134, e178617 (2024).

  17. Mo, Y. et al. ZDHHC20 mediated S-palmitoylation of fatty acid synthase (FASN) promotes hepatocarcinogenesis. Mol. Cancer 23, 274 (2024).

    Google Scholar 

  18. Chaturvedi, S. & Sonawane, A. Recapitulating the potential contribution of protein S-palmitoylation in cancer. Cancer Metastasis Rev. 44, 20 (2024).

    Google Scholar 

  19. Natale, F. et al. Inhibition of zDHHC7-driven protein S-palmitoylation prevents cognitive deficits in an experimental model of Alzheimer’s disease. Proc. Natl. Acad. Sci. USA 121, e2402604121 (2024).

    Google Scholar 

  20. Wei, F. et al. ZDHHC7-mediated S-palmitoylation of ATG16L1 facilitates LC3 lipidation and autophagosome formation. Autophagy 20, 2719–2737 (2024).

    Google Scholar 

  21. Huang, B. et al. Palmitoylation-dependent regulation of GPX4 suppresses ferroptosis. Nat. Commun. 16, 867 (2025).

    Google Scholar 

  22. Zheng, W. et al. S-palmitoylation modulates ATG2-dependent non-vesicular lipid transport during starvation-induced autophagy. Embo J. 44, 2596–2619 (2025).

    Google Scholar 

  23. Xin, L. et al. Methionine Restriction Exerts Anti-Tumor Immunity via Joint Intervention of T-Bet palmitoylation in gastric cancer. Biotechnol. J. 20, e202400574 (2025).

    Google Scholar 

  24. Liu, S. et al. Helicobacter pylori CagA promotes gastric cancer immune escape by upregulating SQLE. Cell Death Dis. 16, 17 (2025).

    Google Scholar 

  25. Xu, M. et al. Palmitoyltransferase ZDHHC3 aggravates nonalcoholic steatohepatitis by targeting s-palmitoylated IRHOM2. Adv. Sci. 10, e2302130 (2023).

    Google Scholar 

  26. Tang, F. et al. A pan-cancer single-cell panorama of human natural killer cells. Cell 186, 4235–4251 (2023).

    Google Scholar 

  27. Mahat, D. B. et al. Single-cell nascent RNA sequencing unveils coordinated global transcription. Nature 631, 216–223 (2024).

    Google Scholar 

  28. Ma, L. et al. Single-cell RNA-seq reveals novel interaction between muscle satellite cells and fibro-adipogenic progenitors mediated with FGF7 signalling. J. Cachexia Sarcopenia Muscle 15, 1388–1403 (2024).

    Google Scholar 

  29. Jiang, H. et al. Revealing the transcriptional heterogeneity of organ-specific metastasis in human gastric cancer using single-cell RNA Sequencing. Clin. Transl. Med. 12, e730 (2022).

    Google Scholar 

  30. Zhai, Y. et al. Single-cell RNA sequencing integrated with bulk RNA sequencing analysis reveals diagnostic and prognostic signatures and immunoinfiltration in gastric cancer. Comput. Biol. Med. 163, 107239 (2023).

    Google Scholar 

  31. Wang, Z. et al. Identifying mitophagy-related genes as prognostic biomarkers and therapeutic targets of gastric carcinoma by integrated analysis of single-cell and bulk-RNA sequencing data. Comput. Biol. Med. 163, 107227 (2023).

    Google Scholar 

  32. Kuppe, C. et al. Spatial multi-omic map of human myocardial infarction. Nature 608, 766–777 (2022).

    Google Scholar 

  33. Li, J., Wu, Z., and Lin, R. Impact of Helicobacter pylori on immunotherapy in gastric cancer. J. Immunother. Cancer 12, e010354 (2024).

  34. Kim, H. D. et al. Survival outcomes of patients with gastric cancer treated with first-line nivolumab plus chemotherapy based on claudin 18.2 expression. Gastric Cancer 28, 74–82 (2025).

    Google Scholar 

  35. Kumar, V. et al. Single-cell atlas of lineage states, tumor microenvironment, and subtype-specific expression programs in gastric cancer. Cancer Discov. 12, 670–691 (2022).

    Google Scholar 

  36. Ko, P. J. & Dixon, S. J. Protein palmitoylation and cancer. EMBO Rep. 19, e46666 (2018).

    Google Scholar 

  37. Yao, H. et al. Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours. Nat. Biomed. Eng. 3, 306–317 (2019).

    Google Scholar 

  38. Shen, Z. H. et al. Unveiling the role of protein palmitoylation in gastric cancer diagnosis via machine learning. Discov. Oncol. 16, 1982 (2025).

    Google Scholar 

  39. Zhang, Z. et al. Palmitoylation of TIM-3 promotes immune exhaustion and restrains antitumor immunity. Sci. Immunol. 9, eadp7302 (2024).

    Google Scholar 

  40. He, Y. et al. Palmitic acid accelerates endothelial cell injury and cardiovascular dysfunction via palmitoylation of PKM2. Adv. Sci. 12, e2412895 (2025).

    Google Scholar 

  41. Rocks, O. et al. An acylation cycle regulates localization and activity of palmitoylated Ras isoforms. Science 307, 1746–1752 (2005).

    Google Scholar 

  42. Plowman, S. J. et al. H-ras, K-ras, and inner plasma membrane raft proteins operate in nanoclusters with differential dependence on the actin cytoskeleton. Proc. Natl. Acad. Sci. USA 102, 15500–15505 (2005).

    Google Scholar 

  43. Runkle, K. B. et al. Inhibition of DHHC20-mediated EGFR palmitoylation creates a dependence on EGFR signaling. Mol. Cell 62, 385–396 (2016).

    Google Scholar 

  44. Zhang, Z. et al. Cardiolipin-mimic lipid nanoparticles without antibody modification delivered senolytic in vivo CAR-T therapy for inflamm-aging. Cell Rep. Med. 6, 102209 (2025).

    Google Scholar 

  45. Papp, T. E. et al. CD47 peptide-cloaked lipid nanoparticles promote cell-specific mRNA delivery. Mol. Ther. 33, 3195–3208 (2025).

    Google Scholar 

  46. Song, P. et al. Palmitic acid and palmitoylation in cancer: understanding, insights, and challenges. Innovation 6, 100918 (2025).

    Google Scholar 

  47. Yang, K. et al. The role of lipid metabolic reprogramming in tumor microenvironment. Theranostics 13, 1774–1808 (2023).

    Google Scholar 

Download references

Acknowledgements

This study was supported by the General Programme of Health Commission of WuXi (No. M202330) and the collaborative custom development of RNA probes at Soochow University (No. P112213323). The authors would like to acknowledge the contributions of the research participants and the technical support from the institutions involved in this project.

Author information

Author notes
  1. These authors contributed equally: Jun Xu, You Hu, Qiao Qiao.

Authors and Affiliations

  1. Department of Gastroenterology, The First Affiliated Hospital of Soochow University, Suzhou, China

    Jun Xu & Yongda Lu

  2. Department of General Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China

    You Hu

  3. Department of Digestive Medicine, Affiliated Hospital of Jiangnan University, Wuxi, China

    Qiao Qiao

  4. Department of Oncology, The First Affiliated Hospital of Soochow University, Suzhou, China

    Fan Cen & Suhua Xia

  5. Animal Experimental Center of the Public Platform, China Pharmaceutical University, Nanjing, China

    Shuoshuo Hou

  6. Department of Basic Medicine, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China

    Hongbao Yang

  7. Department of Thoracic Surgery, Changzheng Hospital, Naval Medical University, Shanghai, Shanghai, China

    Jian Lv

  8. Department of Pathology, Affiliated Hospital of Jiangnan University, Wuxi, China

    Yan Qin

Authors
  1. Jun Xu
    View author publications

    Search author on:PubMed Google Scholar

  2. You Hu
    View author publications

    Search author on:PubMed Google Scholar

  3. Qiao Qiao
    View author publications

    Search author on:PubMed Google Scholar

  4. Yongda Lu
    View author publications

    Search author on:PubMed Google Scholar

  5. Fan Cen
    View author publications

    Search author on:PubMed Google Scholar

  6. Shuoshuo Hou
    View author publications

    Search author on:PubMed Google Scholar

  7. Hongbao Yang
    View author publications

    Search author on:PubMed Google Scholar

  8. Jian Lv
    View author publications

    Search author on:PubMed Google Scholar

  9. Yan Qin
    View author publications

    Search author on:PubMed Google Scholar

  10. Suhua Xia
    View author publications

    Search author on:PubMed Google Scholar

Contributions

J.X., Y.H., and Q.Q. contributed equally to this work. J.X. conceived and designed the study. Y.H. and Q.Q. performed data acquisition, preprocessing, and integration of the TCGA and GEO datasets. Y.D.L. and F.C. developed and optimised the machine-learning framework and conducted model training and validation. S.S.H. and H.B.Y. performed the single-cell and spatial transcriptomic analyses. J.L. supervised the computational experiments and provided methodological guidance. Y.Q. and S.H.X. coordinated the project, provided critical revisions, and secured funding. J.X., Y.H., and Q.Q. drafted the manuscript. Y.D.L., F.C., S.S.H., and H.B.Y. prepared figures and contributed to data visualisation. J.L., Y.Q., and S.H.X. reviewed and edited the manuscript. All authors discussed the results, approved the final version, and agree to be accountable for all aspects of the work.

Corresponding authors

Correspondence to Jian Lv, Yan Qin or Suhua Xia.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Supplementary data (download DOCX )

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xu, J., Hu, Y., Qiao, Q. et al. AI-enabled single-cell dissection of the palmitoylation landscape identifies a multicellular prognostic program in gastric cancer. npj Precis. Onc. (2026). https://doi.org/10.1038/s41698-026-01359-4

Download citation

  • Received: 27 October 2025

  • Accepted: 24 February 2026

  • Published: 07 March 2026

  • DOI: https://doi.org/10.1038/s41698-026-01359-4

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Download PDF

Associated content

Collection

AI Approaches in Drug Design

Advertisement

Explore content

  • Research articles
  • Reviews & Analysis
  • News & Comment
  • Collections
  • Follow us on X
  • Sign up for alerts
  • RSS feed

About the journal

  • Aims & Scope
  • Content types
  • Journal Information
  • Open Access
  • About the Editors
  • Contact
  • Calls for Papers
  • Editorial policies
  • Journal Metrics
  • About the Partner

Publish with us

  • For Authors and Referees
  • Language editing services
  • Open access funding
  • Submit manuscript

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

npj Precision Oncology (npj Precis. Onc.)

ISSN 2397-768X (online)

nature.com footer links

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2026 Springer Nature Limited

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer